Activities of five new fluoroquinolones against Pseudomonas pseudomallei
- 1 June 1988
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 32 (6) , 928-929
- https://doi.org/10.1128/aac.32.6.928
Abstract
Thirty-four isolates of Pseudomonas pseudomallei were tested by a broth microdilution technique for susceptibility to amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin. Ciprofloxacin was the most active agent tested, with an MIC for 90% of the strains tested of 8 micrograms/ml. These in vitro results suggest that the fluoroquinolones tested would not be optimal for therapy of melioidosis.This publication has 5 references indexed in Scilit:
- The new quinolones and their combinations with other agents for therapy of severe infectionsJournal of Antimicrobial Chemotherapy, 1986
- In Vitro Susceptibility of Strains of Pseudomonas pseudomallei Isolated in Thailand and Hong Kong to Some Newer -Lactam Antibiotics and Quinolone DerivativesThe Journal of Infectious Diseases, 1986
- The fluoroquinolones: pharmacology, clinical uses, and toxicities in humansAntimicrobial Agents and Chemotherapy, 1985
- Human-to-Human Transmission of Pseudomonas pseudomalleiAnnals of Internal Medicine, 1975
- Pulmonary melioidosis. Observations in thirty-nine cases.Published by Elsevier ,1975